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Objective: The purpose of this article is to familiarize the reader with the issue of bone
loss that accompanies severe burn injury. Why is this important? How does it happen?
How can we treat it? Methods: The published findings on this subject are reviewed and
integrated into a conceptual framework. Results: Bone loss occurs quickly following a
severe burn, is sustained, and increases the risk of postburn fracture. The likely mech-
anisms responsible are the increase in endogenous glucocorticoid production resulting
from the stress response and resorptive cytokines resulting from the systemic inflam-
matory response and likely aggravated by progressive vitamin D deficiency. Calcium
metabolism is also disrupted as the patients develop hypocalcemic hypoparathyroidism
likelyduetoanupregulationoftheparathyroidcalcium-sensingreceptor,possiblydueto
inflammatory cytokine stimulation. Treatment is achieved by use of anabolic agents and
vitamin D supplementation. Studies of acute administration of the antiresorptive agent
pamidronate are also promising. Conclusion: Postburn bone loss should be looked for
in patients with a burn injury of 40% or greater total body surface area. The cause is
inherenttotheadaptivemechanismsfollowingburninjury.Methodsareavailabletotreat
this condition.
There is now incontrovertible evidence that bone and calcium metabolism are ad-
versely affected by severe burn injury. In adults, intraoperative iliac crest bone biopsies
demonstrated reduced bone formation approximately 3 weeks postburn.1 While the effects
of these histomorphometric findings on bone density and fracture incidence have not been
pursued, similar findings have been found in children with a burn injury of 40% or greater
total body surface area (TBSA)2 with associated reduction in bone density and an increase
in extrapolated annual fracture incidence by nearly twofold in boys and by approximately
one third in girls.3 There are no similar data available for adults, including firefighters, who
havebeenseverelyburned,inpartbecausepostburnfractureincidenceisnottrackedbyany
database. Furthermore, the mechanisms involved in bone loss may be related to specific
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types of adaptive processes that occur in response to the burn injury, such as the stress and
inflammatory responses seen postburn. To the extent that these processes occur in other
settings, the findings in burn victims may also apply to other clinical conditions in which
bone loss was not suspected.
SKELETAL CONSEQUENCES OF BURNS
The mechanisms to be covered concern 2 discrete alterations in bone and calcium
metabolism following the burn injury: the first is actual bone loss and the second is disor-
dered calcium metabolism. The actual relationship between the 2 effects is not completely
clear. After a description of the operative mechanisms to the extent they are known, we will
attempt to draw a connection between disordered calcium metabolism and bone loss.
Bone loss
The bone loss is manifested by an approximate 2% loss of total body bone mineral content
(BMC) by 2 months postburn, increasing to about 3.5% by 6 months, with lumbar spine
BMC falling by about 8% by 2 months postburn and remaining the same at 6 months
postburn,4 as determined by dual-energy x-ray absorptiometry (DXA) on a QDR 4500A
absorptiometer (Hologics, Waltham, MA). While growth velocity is reduced for the first
year postburn5 and DXA tends to underread density for smaller children,6 the fall in BMC
andbonemineraldensity(BMD)whenmeasuredlongitudinallyremainvalidbecauseactual
height is not lost. However, because DXA measurements are areal, that is, 2-dimensional
rather than 3-dimensional, we cannot be certain how much bone strength is lost if there is a
compensatory increase in bone volume. In addition, countering any compensatory increase
in bone width to try to maintain strength is the loss of skeletal loading secondary to muscle
atrophy resulting from hypermetabolism and negative nitrogen balance.7
The way we believe this bone loss occurs is as follows. Within 24 hours of burn in-
jury, there is a rise in proinflammatory cytokines, notably interleukin (IL)-1β and IL-6.8
Both of these cytokines stimulate osteoblasts to increase production of the ligand of the
receptor activator of nuclear transcription factor κB (RANK ligand, or RANKL), which
stimulates marrow stromal cells to differentiate into osteoclasts, resulting in an increase
in bone resorption.9 Moreover, at some time before 2 weeks postburn, there is a rise in
endogenous glucocorticoid production, which, as expressed by measurements of urine free
cortisol, can reach an 8-fold elevation above normal.2,10 Glucocorticoids can acutely stim-
ulate osteoblast production of RANKL,11 thus further increasing osteoclastogenesis and
bone resorption. This acute surge in bone resorption has not yet been documented but all
the causative mechanisms are in place to produce it.
Moving on in time, urine free cortisol excretion remains elevated for the entire period
of the acute burn, at least 3 months.12 Subsequent effects of glucocorticoid on bone ap-
parent by 2 weeks postburn are an absence of osteoblasts on the bone surface and reduced
biochemical markers of marrow stromal cell differentiation into osteoblasts, such as alka-
linephosphatasebonemorphogeneticprotein,andcore-bindingfactorantigen-1(cbfa-1).10
Thus, because osteoblasts are now largely absent, bone resorption cannot be elevated, even
in the presence of high circulating levels of IL-1β and IL-6, which are 3-fold and 100-fold
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elevated, respectively. Urinary deoxypyridinoline, a biomarker of collagen cross-links re-
sultingfromresorption,isdetectablebutthelevelsarebelowthoseforage-relatedcontrols.2
However, given the reduction in osteoblast differentiation and apoptosis, the likely explana-
tion for the disappearance of osteoblasts, bone formation is virtually absent and bone loss
continues. Thus, bone is lost because of the acute effect of endogenous steroids, the pre-
sumed synergistic pro-resorptive effects of the endogenous glucocorticoids and cytokines




calcium, and despite frequent parenteral calcium supplementation as needed, determined to
be 50 to 70 mg/(kg d).4 Furthermore, urinary calcium excretion is elevated. In children this
elevation is twice the normal value,2,4 and in a burned sheep model, fractional excretion
of calcium is not different from sham-burned animals despite significantly lower blood
calcium.14 Moreover, serum concentration of parathyroid hormone (PTH) in children is
inappropriately low for the blood calcium levels,13 indicating that children with burns have
not only hypocalcemia and hypercalciuria but hypoparathyroidism as well. The modified
Ellsworth-Howard test, in which PTH is administered subcutaneously and an increase in
urinary cyclic AMP and phosphate excretion is observed, produced only a blunted response
in children with burns, suggesting PTH resistance.13 All these findings could be explained
by magnesium depletion, and a good explanation for this hypothesis is that burn patients
are resuscitated with Ringer’s lactate solution, which does not contain magnesium.14
Using the magnesium infusion-retention test described by Rude,13,15 all children with
ab urn injury of 40% or greater TBSA at approximately 2 weeks postburn were magnesium
depleted.13 However, when half of the children were magnesium repleted and PTH and
calcium were reexamined, the magnesium-replete children did not have either PTH or
calcium levels significantly higher than their magnesium-depleted counterparts.16 Thus
magnesium depletion, while present, was not the explanation for this disordered calcium
metabolism.
The calcium-sensing receptor
The calcium-sensing receptor, a membrane-bound G-protein-coupled receptor is present
primarily but not exclusively on the chief cells of the parathyroid gland. It has the ability
to sense both blood calcium and magnesium concentrations.17 The exact mechanism of
upregulation or downregulation has not been published. With upregulation, as in hypercal-
ciurichypocalcemia,17 theserumPTHlevelsareinappropriatelylow.Ittakeslesscirculating
calciumtoreduceparathyroidglandsecretionof PTH.Theconsequenceofthisphenomenon
is a reduced set point for calcium stimulation of PTH secretion. This is exactly what we
see in children with burns, with low PTH levels, low blood ionized calcium, and high
urinary calcium.13 Conversely, with primary or secondary hyperparathyroidism, there is a
downregulation of the calcium-sensing receptor, indicating that it takes higher than normal
concentrations of circulating calcium to turn off the signal for PTH secretion, resulting in
hypercalcemia and hyperparathyroidism.
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Studies of burned and sham-burned sheep in our laboratory and in collaboration with
the laboratory of Brown and colleagues in Boston14 have demonstrated a 50% upregulation
of the calcium-sensing receptor in the parathyroids of the burned sheep compared to the
sham-burnedcontrols,thusprovidingevidencesupportingcalciumreceptorupregulationas
the mechanism that may modify calcium metabolism following burn injury. Furthermore,
studiesbyNielsenetalinBrown’slaboratoryusingbovineparathyroidchiefcells,18 Toribio
et al19 using horse parathyroid, and Canaff and Hendy20 demonstrated that both IL-1β18,19
and IL-619,20 are capable of up-regulating the parathyroid gland calcium-sensing receptor
with the consequences described above.
How do bone loss and disordered calcium metabolism interact?
While the upregulation of the calcium-sensing receptor may explain the hypocalcemia,
hypercalciuria, and hypoparathyroidism we observe following burn injury, is there a way
thatthese2phenomenamayinteract?Itisnotthatweknowforcertainallthewaysinwhich
thesefindingsplayononeanother,butatleast2typesofinteractioncanbepostulated.These
form a unique adaptation of the body to burn injury. One way in which these 2 adaptations
may interact is that the excessive endogenous glucocorticoid production drastically reduces
surface osteoblasts available to interact with the proinflammatory cytokines to produce
osteoclastogenesis.Thusitispossiblethatintheabsenceofosteoblasts,theparathyroidchief
cells may be a secondary target for the proinflammatory cytokines, which would then result
in the hypocalcemic, hypoparathyroid state observed following burn injury. The second
interaction then could be considered to be that the absence of osteoblasts will indirectly
result in the hypoparathyroid-associated urinary calcium wasting, making it impossible to
deposit calcium in bone.
And the inflammatory response, which results in high levels of pro-inflammatory
cytokines, combine to produce the complex of events described above. Of note is that
these adaptive responses can be seen in other conditions and should be deemed capable of
producing similar effects on bone and calcium metabolism.
Loose ends: Zinc and vitamin D
To make it clear that we do not have a neat package, we need to acknowledge that burn
injuries also create other disturbances in metabolism that may interfere with bone and
calcium homeostasis. While there may yet be many unidentified factors that could play
a role in the pathogenesis of bone loss, two nutrients that burn patients are known to be
deficient in are zinc and vitamin D.
Zinc plays a role in the cross-linking of molecules of type I collagen. It is reported
to come out of bone following burn injury.21 Furthermore, plasma zinc remains low while
urinary zinc excretion is elevated after a burn.22 In addition, zinc plays a role in the inflam-
matory response, and the concentration of zinc in the burn wound exudates is consistently
higher than it is in plasma.22 Requirements for zinc during recuperation from burn injury
have not been established.
More is known about the problem of vitamin D deficiency in burns, although the
implications of this finding are still not clear. At Shriners Burns Hospital in Galveston, all
patients receive at least 400 IU/d of vitamin D, representing the former recommended daily
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allowance set by the Food and Nutrition Board of the Institute of Medicine of the National
AcademyofSciences.Itrepresentstwicethedailyreferenceintakethatthissameinstitution
has used to replace the recommended dietary allowances. Thus 200 IU/d of vitamin D is
now the established recommendation for children.23 Vitamin D deficiency by definition
is the lower-than-normal serum concentration of 25-hydroxy-vitamin D (25(OH)D), the
main circulating form of vitamin D after undergoing 25-hydroxylation in the liver by the
cytochrome p450–dependent enzyme vitamin D 25-hydroxylase. There is, however, debate
over whether the lower limit of circulating 25(OH)D should be reset to one in which serum
PTHlevelsarenormal,currentlyrecommendedtobe30ng/mL,a33%increaseinthelower
limit of normal levels.
It is not known exactly when vitamin D deficiency develops following a burn injury.
While serum vitamin D levels are lower by 3 weeks following burn injury, it is not pos-
sible to evaluate the status of 25(OH)D because free 25(OH)D is no longer measured nor
are there definitions of vitamin D sufficiency or deficiency based on free 25(OH)D. How-
ever, by 6 months postburn, most constitutive proteins are back to normal.24 As early as
14 months after burn injury, serum 25(OH)D levels are low.25 A previous cross-sectional
study looking at children at 2 and at 7 years postburn26 showed that at 2 years, nearly all
serumlevelsof25(OH)Dwerelow,whilelevelsofthebiologicallyactivemetabolite1α,25-
di-hydroxyvitaminD(1,25(OH)2D)wereallnormal.However,at7yearspostburn,notonly
were all the serum levels of 25(OH)D low but half of the circulating levels of 1,25(OH)2D
were also low, suggesting a progressive deficiency.
Why is vitamin D deficiency important in burns? We have evidence of a direct re-
lationship between serum levels of 25(OH)D and lumbar spine bone mineral density Z
score.26 Furthermore, correlations between serum levels of 25(OH)D and bone density
have been shown in other studies.27−30 Postdischarge supplementation with a multivitamin
containing 400 IU has been recommended25,26 because following a burn injury, the skin
becomes biochemically abnormal. Burn scar and adjacent normal-appearing skin not only
have their capacity to convert 7-dehydrocholesterol, the vitamin D precursor in skin, to
pre-vitamin D3 reduced to 25–30% of normal, but they will also contain reduced amounts
of the 7-dehydrocholesterol substrate.25 This finding may indicate a persistent biochemical
abnormality of skin cholesterol biosynthesis of indefinite duration following a burn.
MANAGEMENT
Published studies of the anabolic agents recombinant human growth hormone31 and
oxandrolone32 have shown that there is an increase in lean body mass after 6 months
of daily use, and only at 1 year postburn is there a significant increase in BMC as seen
by DXA studies. Furthermore, with neither drug is there an increase in areal BMD of
the lumbar spine, only an increase in BMC of the total body and lumbar spine. Because
areal BMD is the quotient of BMC and bone area, the increase in BMC and not BMD
implies a proportionate increase in bone area in patients treated with these anabolic agents.
Thus the bone becomes bigger and biomechanically stronger and theoretically less likely to
fracture. However, because BMD Z scores remain below normal31,32 the amount of min-
eralization per unit area (BMD) of the bone does not differ between treated and untreated
subjects.WhetherthedecreasedBMDstillconstitutesariskfactorforfracturesisunknown.
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Therefore, the trial of an antiresorptive agent such as a bisphosphonate given acutely after
burn injury might result in the preservation of BMD.
Preliminary data published in 2005 indicate that intravenous administration of the
bisphosphonate pamidronate at a dose of 1.5 mg/kg in 5% dextrose and water over 12 hours
within the first 10 days of burn injury and then again 1 week later to children with a burn
injury of 40% or greater TBSA resulted in prevention of bone loss for the first 6 months
postburn, with trabecular, or cancellous, bone more greatly affected than cortical bone and
without any increase in postburn hypocalcemia.4
Thus while we still do not fully understand all the effects of burn injury on bone
metabolism, the use of antiresorptives, anabolic agents, and vitamin D should minimize the
damage to bone and calcium metabolism resulting from the burn injury. Furthermore, the
understanding obtained from the study of burn effects on bone and calcium metabolism
may result in beneficial applications to the study and treatment of other conditions in which
similar adaptive responses are operative.
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